Cargando…

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67

BACKGROUND: LA67 is a derivative of triptolide that exhibits strong antitumor activity. This derivative has a better safety profile than triptolide, but is limited by poor aqueous solubility. AIM AND METHODS: To improve solubility and further increase therapeutic efficacy, we prepared LA67-loaded po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Minhu, Jin, Mingji, Han, Mingfeng, Zang, Yingda, Li, Chuangjun, Zhang, Dongming, Huang, Wei, Gao, Zhonggao, Yin, Xuezhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245463/ https://www.ncbi.nlm.nih.gov/pubmed/32547014 http://dx.doi.org/10.2147/IJN.S241577

Ejemplares similares

LA67 Liposome-Loaded Thermo-Sensitive Hydrogel with Active Targeting for Efficient Treatment of Keloid via Peritumoral Injection
por: Wan, Hongshuang, et al.
Publicado: (2023)

A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution
por: Ma, Mingshu, et al.
Publicado: (2012)

Claulansine F–Donepezil Hybrids as Anti-Alzheimer’s Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities
por: Zang, Yingda, et al.
Publicado: (2021)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin, Mingji, et al.
Publicado: (2018)

Ginseng polysaccharides: Potential antitumor agents
por: Tao, Ruizhi, et al.
Publicado: (2023)

Chiral Flavonoids as Antitumor Agents
por: Pinto, Cláudia, et al.
Publicado: (2021)

Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity
por: Yang, Qichao, et al.
Publicado: (2022)

Discovery of a Novel Hybrid of Vorinostat and Riluzole as a Potent Antitumor Agent
por: Xu, Qifu, et al.
Publicado: (2020)

Design, synthesis, and biological evaluation of biotinylated colchicine derivatives as potential antitumor agents
por: Wang, Chao, et al.
Publicado: (2021)

Salmonella as an Innovative Therapeutic Antitumor Agent
por: Chang, Wen-Wei, et al.
Publicado: (2014)

Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes
por: Wang, Mengjiao, et al.
Publicado: (2019)

Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015)

Effects of Antitumor Agents on Subcutaneous Implants and Hepatic Metastases of Colon Carcinoma 26 in Mice
por: Iigo, Masaaki, et al.
Publicado: (1992)

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents
por: Wang, Chao, et al.
Publicado: (2023)

The heterogeneity and complexity of Cannabis extracts as antitumor agents
por: Baram, Liran, et al.
Publicado: (2019)

Indole Antitumor Agents in Nanotechnology Formulations: An Overview
por: Russo, Eleonora, et al.
Publicado: (2023)

Development of high drug-loading nanomicelles targeting steroids to the brain
por: Zheng, Sijia, et al.
Publicado: (2013)

New Oral Formulation and in Vitro Evaluation of Docetaxel-Loaded Nanomicelles
por: Hekmat, Atefeh, et al.
Publicado: (2016)

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
por: Zhang, Xinyi, et al.
Publicado: (2020)

Preparation and properties of Pue-loaded HA-ADH-PS nanomicelles
por: Wang, Huiru, et al.
Publicado: (2021)

Formulation of Nanomicelles Loaded with Cannabidiol as a Platform for Neuroprotective Therapy
por: Yordanov, Yordan, et al.
Publicado: (2022)

Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles
por: Yuan, Xue, et al.
Publicado: (2017)

Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles
por: Wang, Jun, et al.
Publicado: (2011)

Potentiating antitumor immunity with αGC-loaded exosomes
por: Gehrmann, Ulf, et al.
Publicado: (2013)

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022)

CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer
por: Cao, Yingying, et al.
Publicado: (2021)

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
por: Xing, Rui, et al.
Publicado: (2021)

An Overview of Structurally Modified Glycyrrhetinic Acid Derivatives as Antitumor Agents
por: Xu, Bing, et al.
Publicado: (2017)

Structural Features of Antitumor Titanium Agents and Related Compounds
por: Caruso, Francesco, et al.
Publicado: (2005)

Synthesis and Evaluation of Novel Organogermanium Sesquioxides As Antitumor Agents
por: Zhang, Chun Li, et al.
Publicado: (2009)

Current and new antitumor necrosis factor agents in perspective
por: Maini, Ravinder N
Publicado: (2004)

β-blockers: a novel class of antitumor agents
por: Ji, Yi, et al.
Publicado: (2012)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

Potential clinical application of interleukin-27 as an antitumor agent
por: Yoshimoto, Takayuki, et al.
Publicado: (2015)

Disaccharides obtained from carrageenans as potential antitumor agents
por: Calvo, Gustavo H., et al.
Publicado: (2019)

p-Cymene Complexes of Ruthenium(II) as Antitumor Agents
por: Pujante-Galián, María Angeles, et al.
Publicado: (2020)

Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents
por: Castro, Jessica, et al.
Publicado: (2021)

Synthesis and Discovery of Ligustrazine–Heterocycle Derivatives as Antitumor Agents
por: Ma, Shitang, et al.
Publicado: (2022)

Discovery of Novel Quinazoline Derivatives as Potent Antitumor Agents
por: Niu, Zhenxi, et al.
Publicado: (2022)

Antitumor Applications of Photothermal Agents and Photothermal Synergistic Therapies
por: Li, Chaowei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_od4nsa85v76cjb9d3tohuf273d